Related Experiment Video
Updated: Aug 16, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation
Judith Aharon-Peretz1, Samih Badarny, Hanna Rosenbaum
1Department of Neurology, Rambam Medical Center, Haifa, Israel. jaharon@rambam.health.gov.il
Abstract:
Mutations in the glucocerebrosidase (GBA) gene have been recently identified as contributory to Parkinson disease (PD) in Ashkenazi Jews. In the present study, the clinical characteristics of Ashkenazi patients with PD with GBA mutations (n = 40) were compared to those of Ashkenazi patients with PD without any known GBA mutation (n = 108). The overall clinical manifestations and age at disease onset did not differ in patients with GBA mutations compared to patients without mutations.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Genetic Lingo
Parkinson's Disease: Overview
Pedigree Analysis
Neural Regulation

